ALGS vs J · rev $3.6M vs P/E 36, $14.40B cap
Aligos Therapeutics Inc (ALGS) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
J does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ALGS and J stock pages for the full models.
Not investment advice.